Loading...
Co-prescribing naloxone does not increase liability risk
The opioid overdose epidemic claims the lives of tens of thousands of Americans every year. Opioid overdose is reversible by the administration of naloxone, a pure antagonist now available in formulations specifically designed and labeled for layperson use. Despite broad support for layperson access...
Na minha lista:
| Udgivet i: | Subst Abus |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5567808/ https://ncbi.nlm.nih.gov/pubmed/27648764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08897077.2016.1238431 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|